Brain and Spine (Jan 2021)
Bariatric surgery versus community weight management intervention for the treatment of idiopathic intracranial hypertension (IIH:WT): a randomized controlled trial
- S. Mollan,
- J.L. Mitchell,
- R. Ottridge,
- M. Aguiar,
- A. Yiangou,
- Z. Alimajstorovic,
- D. Cartwright,
- O. Grech,
- G. Lavery,
- C. Westgate,
- V. Vijay,
- W. Scotton,
- B. Wakerley,
- T. Matthews,
- A. Ansons,
- S. Hickman,
- J. Benzimra,
- C. Rick,
- R. Singhal,
- A. Tahrani,
- K. Brock,
- E. Frew,
- A. Sinclair
Affiliations
- S. Mollan
- University Hospitals Birmingham NHS Foundation Trust, Department of Neuro-Ophthalmology, Birmingham, United Kingdom
- J.L. Mitchell
- University of Birmingham, Metabolic Neurology, Institute of Metabolism and Systems Research, Birmingham, United Kingdom
- R. Ottridge
- University of Birmingham, Birmingham Clinical Trials Unit, Birmingham, United Kingdom
- M. Aguiar
- University of Birmingham, Health Economics Unit, Institute of Applied Health Research, Birmingham, United Kingdom
- A. Yiangou
- University of Birmingham, Metabolic Neurology, Institute of Metabolism and Systems Research, Birmingham, United Kingdom
- Z. Alimajstorovic
- University of Birmingham, Metabolic Neurology, Institute of Metabolism and Systems Research, Birmingham, United Kingdom
- D. Cartwright
- University of Birmingham, Institute of Metabolism and Systems Research, Birmingham, United Kingdom
- O. Grech
- University of Birmingham, Metabolic Neurology, Institute of Metabolism and Systems Research, Birmingham, United Kingdom
- G. Lavery
- University of Birmingham, Institute of Metabolism and Systems Research, Birmingham, United Kingdom
- C. Westgate
- University of Birmingham, Metabolic Neurology, Institute of Metabolism and Systems Research, Birmingham, United Kingdom
- V. Vijay
- University of Birmingham, Metabolic Neurology, Institute of Metabolism and Systems Research, Birmingham, United Kingdom
- W. Scotton
- University of Birmingham, Metabolic Neurology, Institute of Metabolism and Systems Research, Birmingham, United Kingdom
- B. Wakerley
- University of Birmingham, Metabolic Neurology, Institute of Metabolism and Systems Research, Birmingham, United Kingdom
- T. Matthews
- University Hospitals Birmingham NHS Foundation Trust, Department of Neuro-Ophthalmology, Birmingham, United Kingdom
- A. Ansons
- Manchester University NHS Foundation Trust, Manchester, United Kingdom
- S. Hickman
- Royal Hallamshire Hospital, Department of neurology, Sheffield, United Kingdom
- J. Benzimra
- Royal Devon and Exeter NHS Trust, Department of Ophthalmology, Exeter, United Kingdom
- C. Rick
- University of Nottingham, Nottingham Clinical Trials Unit, Nottingham, United Kingdom
- R. Singhal
- University Hospitals Birmingham, Upper GI Unit and Minimally Invasive Unit, Birmingham, United Kingdom
- A. Tahrani
- University of Birmingham, Institute of Metabolism and Systems Research, Birmingham, United Kingdom
- K. Brock
- University of Birmingham, Cancer Research UK Clinical Trials Unit, Birmingham, United Kingdom
- E. Frew
- University of Birmingham, Health Economics Unit, Institute of Applied Health Research, Birmingham, United Kingdom
- A. Sinclair
- University of Birmingham, Metabolic Neurology, Institute of Metabolism and Systems Research, Birmingham, United Kingdom
- Journal volume & issue
-
Vol. 1
p. 100755
